CC-1088
Term · Oncology and biomedicine · MLC-T-ONC-001511
A drug that is being studied in the treatment of cancer. It is similar but not identical to thalidomide. CC-1088 belongs to the family of drugs called angiogenesis inhibitors.
| Identifier | MLC-T-ONC-001511 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001511",
"term": "CC-1088",
"field": "Oncology and biomedicine",
"definition": "A drug that is being studied in the treatment of cancer. It is similar but not identical to thalidomide. CC-1088 belongs to the family of drugs called angiogenesis inhibitors.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/cc-1088/"
}
Record 4,352 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.